A Prospective Randomized Study Evaluating the Recurrence Rate of Chronic Subdural Hematoma After Placing a Subperiosteal Drainage Compared to a Subdural Drainage
Launched by KANTONSSPITAL AARAU · Jun 2, 2013
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
Chronic subdural haematoma (cSDH) is one of the most frequent neurosurgical entities, affecting elderly people and associated with substantial morbidity and mortality. Its incidence is reported to be 1.7-13.1 per 100000 inhabitants per year, yet there has been a steady increasing incidence as the result of prolonged life expectancy in recent years. Surgical treatment is recommended in case of neurological symptoms. In the only evidence based review of the different surgical treatment modalities of cSDH, Weigels study group concluded that bure-hole craniostomy with irrigation and drainage ha...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient at least 18 years of age presenting with a symptomatic chronic subdural hematoma
- • Chronic subdural hematoma verified on cranial CT or MRI
- Exclusion Criteria:
- • The surgeon decides based on intraoperative conditions to perform a craniotomy (e.g. acute hematoma indicating a craniotomy)
- • Chronic subdural hematoma caused by another underlying illness (e.g. caused by over-drainage of a vp-shunt)
- • no informed consent
About Kantonsspital Aarau
Kantonsspital Aarau is a leading healthcare institution in Switzerland, renowned for its commitment to high-quality patient care and innovative medical research. As a prominent clinical trial sponsor, the hospital actively engages in advancing medical knowledge through rigorous clinical studies that adhere to ethical standards and regulatory guidelines. With a multidisciplinary team of experienced healthcare professionals and researchers, Kantonsspital Aarau fosters collaborative partnerships aimed at developing new therapeutic interventions and improving health outcomes. The institution is dedicated to enhancing clinical practice through evidence-based research, thereby contributing to the advancement of medical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarau, Aargau, Switzerland
Basel, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials